#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3757548	Functional	Antiviral activity against Japanese encephalitis virus	Japanese encephalitis virus	2	ALA3751697	organism-based format	Scientific Literature
2.	ALA696554	Functional	Tested for inhibition against 2.35 nM ATPase activity of Japanese encephalitis virus (JEV) in presence of ATP adjusted to 1*10e-5 of Km of enzyme	Japanese encephalitis virus	2	ALA1145091	organism-based format	Scientific Literature
3.	ALA698329	Functional	Tested for inhibition against Helicase activity of Japanese encephalitis virus (JEV) in presence of ATP adjusted to 235 uM and 4.7 pM of DNA substrate	Japanese encephalitis virus	13	ALA1145091	organism-based format	Scientific Literature
4.	ALA698330	Functional	Tested for inhibition against Helicase activity of Japanese encephalitis virus (JEV) in presence of ATP adjusted to 235 uM and 4.7 pM of RNA duplex substrate	Japanese encephalitis virus	6	ALA1145091	organism-based format	Scientific Literature
5.	ALA698331	Functional	Tested for inhibition against 2.35 pM ATPase activity of Japanese encephalitis virus (JEV) in presence of ATP adjusted to 1*10e-4 of Km of enzyme	Japanese encephalitis virus	2	ALA1145091	organism-based format	Scientific Literature
6.	ALA704119	Functional	Inhibitory dose of compound required to inhibit cytopathogenic effects of Japanese encephalitis virus with najayama strain in vero cells	Japanese encephalitis virus	2	ALA1124192	organism-based format	Scientific Literature
7.	ALA701684	Functional	Tested for inhibition of virus-induced cytopathogenic effect and cytotoxicity of compound against Japanese encephalitis virus with najayama strain in vero cell	Japanese encephalitis virus	2	ALA1124192	organism-based format	Scientific Literature
8.	ALA878109	Functional	Inhibitory activity of compound against japanese encephalitis virus (JBE) was evaluated in vitro; Inactive	Japanese encephalitis virus	9	ALA1129515	organism-based format	Scientific Literature
9.	ALA1677702	Functional	Antiviral activity against Japanese encephalitis virus RP-9 infected in C57BL/6 mouse assessed as mouse survival rate at 1 ug, ip administered one day before and 1 day after viral infection measured after 25 days post infection relative to solvent treated control	Japanese encephalitis virus	4	ALA1671729	organism-based format	Scientific Literature
10.	ALA1677703	Functional	Antiviral activity against Japanese encephalitis virus RP-9 infected in Stat-1-knockout immunodeficient C57BL/6 mouse assessed as mouse survival rate at 1 ug, ip administered one day before and 1 day after viral infection measured after 25 days post infection relative to solvent treated control	Japanese encephalitis virus	2	ALA1671729	organism-based format	Scientific Literature
11.	ALA1677704	Functional	Antiviral activity against Japanese encephalitis virus RP-9 infected in Ig-mu chain-knockout immunodeficient C57BL/6 mouse assessed as mouse survival rate at 1 ug, ip administered one day before and 1 day after viral infection measured after 25 days post infection relative to solvent treated control	Japanese encephalitis virus	2	ALA1671729	organism-based format	Scientific Literature
12.	ALA1677705	Functional	Antiviral activity against Japanese encephalitis virus RP-9 infected in CD8-alpha chain-knockout immunodeficient C57BL/6 mouse assessed as mouse survival rate at 1 ug, ip administered one day before and 1 day after viral infection measured after 25 days post infection relative to solvent treated control	Japanese encephalitis virus	1	ALA1671729	organism-based format	Scientific Literature
13.	ALA1677706	Functional	Antiviral activity against Japanese encephalitis virus RP-9 infected in C57BL/6 mouse assessed as mouse survival rate at 1 ug, ip administered one day before viral infection measured after 25 days post infection relative to solvent treated control	Japanese encephalitis virus	2	ALA1671729	organism-based format	Scientific Literature
14.	ALA1677707	Functional	Antiviral activity against Japanese encephalitis virus RP-9 infected in C57BL/6 mouse assessed as mouse survival rate at 1 ug, ip administered simultaneously with viral infection measured after 25 days post infection relative to solvent treated control	Japanese encephalitis virus	2	ALA1671729	organism-based format	Scientific Literature
15.	ALA1677708	Functional	Antiviral activity against Japanese encephalitis virus RP-9 infected in C57BL/6 mouse assessed as mouse survival rate at 1 ug, ip administered one day after viral infection measured after 25 days post infection relative to solvent treated control	Japanese encephalitis virus	2	ALA1671729	organism-based format	Scientific Literature
16.	ALA989566	Functional	Antiviral activity against Japanese encephalitis virus GP78 infected BALB/c mouse assessed as reduction in mortality rate at 25 mg/kg, ip twice daily administered 1 day post viral-challenge	Japanese encephalitis virus	1	ALA1143410	organism-based format	Scientific Literature
17.	ALA990379	Functional	Antiviral activity against Japanese encephalitis virus GP78 infected BALB/c mouse assessed as reduction of activated microglia in mouse brain at 25 mg/kg, ip twice daily	Japanese encephalitis virus	1	ALA1143410	organism-based format	Scientific Literature
18.	ALA990380	Functional	Antiviral activity against Japanese encephalitis virus GP78 infected BALB/c mouse assessed as inhibition of viral proteins in mouse brain at 25 mg/kg, ip twice daily after 8 to 9 days by immunoblot	Japanese encephalitis virus	1	ALA1143410	organism-based format	Scientific Literature
19.	ALA990381	Functional	Antiviral activity against Japanese encephalitis virus GP78 infected BALB/c mouse assessed as inhibition of viral mRNA transcript in mouse brain at 25 mg/kg, ip twice daily after 8 to 9 days	Japanese encephalitis virus	1	ALA1143410	organism-based format	Scientific Literature
20.	ALA946481	Functional	Antiviral activity against Japanese encephalitis virus in C6 cells assessed as inhibition of virus-induced cytopathogenicity	Japanese encephalitis virus	1	ALA1156462	organism-based format	Scientific Literature